Jeffrey W. Dunn has served as our President and Chief Executive Officer and as the Chairman of our board of directors since our inception in April 2008. Prior to joining SI BONE, Mr. Dunn served as Chief Executive Officer of INBONE Technologies, Inc., an ankle replacement and small bone fusion

Timothy E. Davis, Jr. has served as a member of our board of directors since our inception in April 2008. Mr. Davis has served as President and Chief Executive Officer of Active Implants, LLC, a company that provides orthopedic implant solutions, since February 2017.

Mark J. Foley is currently President and CEO of Revance Therapeutics and has served as its Board member since September 2017. Mr. Foley brings more than 30 years of operational and investment experience in the healthcare arena. Previously, Mr. Foley served as Managing Director at RWI Ventures, a

John G. Freund, M.D. has served as a member of our board of directors since January 2013. Dr. Freund founded Skyline Ventures, a venture capital firm, in October 1997 and has served as a Managing Director of Skyline since then. Prior to joining Skyline, Dr.

Jeryl Lynn Hilleman is a member of the Board of Directors and Audit Committee Chair of public and private companies including  Novocure , a commercial international oncology company delivering a novel device therapy for solid tumors called Tumor Treating Fields (Nasdaq: NVCR) and  Minerva

Gregory K. Hinckley has served as a member of our board of directors since January 2011. In 2017, Mr. Hinckley retired as president of Mentor Graphics Corporation, a leader in electronic design automation, after serving in that role for nearly 20 years. Prior to Mentor, Mr.

Karen A. Licitra has served as a member of our board of directors since August 2015. From January 2014 through August 2015, Ms. Licitra served as Corporate Vice President, Worldwide Government Affairs & Policy at Johnson & Johnson, a medical devices, pharmaceutical, and consumer packaged goods

Keith C. Valentine has served as a member of our board of directors since August 2015. Since June 2015, Mr. Valentine has also served as President, Chief Executive Officer and a member of the board of directors of SeaSpine Holdings Corporation, a global medical technology company.